SignalPath CEO and leadership

Brad co-founded SignalPath and served as Chair of the Board of Directors since its inception in 2014. He took the reins as CEO in 2017. He continues to practice part time as a medical oncologist and is an active investigator. His deep passion for SignalPath’s mission stems from his time conducting trials in both academics and community practice. Prior to coming to SignalPath, he served as Senior Medical Director at Flatiron Health, a Google-backed startup working to accelerate treatment and research in oncology, and was on the faculty at Duke University, where he led a clinical informatics research team. Brad received his BA from the University of Pennsylvania, his MD from UT Southwestern, and his MBA from Duke University’s Fuqua School of Business. He completed his fellowship in hematology and oncology at Duke University. He and his wife have 2 young children keeping them busy.

Phil Perez is a Chief Commercial Officer at SignalPath.

Brad co-founded SignalPath and served as Chair of the Board of Directors since its inception in 2014. He took the reins as CEO in 2017. He continues to practice part time as a medical oncologist and is an active investigator. His deep passion for SignalPath’s mission stems from his time conducting trials in both academics and community practice. Prior to coming to SignalPath, he served as Senior Medical Director at Flatiron Health, a Google-backed startup working to accelerate treatment and research in oncology, and was on the faculty at Duke University, where he led a clinical informatics research team. Brad received his BA from the University of Pennsylvania, his MD from UT Southwestern, and his MBA from Duke University’s Fuqua School of Business. He completed his fellowship in hematology and oncology at Duke University. He and his wife have 2 young children keeping them busy.

Brad co-founded SignalPath and served as Chair of the Board of Directors since its inception in 2014. He took the reins as CEO in 2017. He continues to practice part time as a medical oncologist and is an active investigator. His deep passion for SignalPath’s mission stems from his time conducting trials in both academics and community practice. Prior to coming to SignalPath, he served as Senior Medical Director at Flatiron Health, a Google-backed startup working to accelerate treatment and research in oncology, and was on the faculty at Duke University, where he led a clinical informatics research team. Brad received his BA from the University of Pennsylvania, his MD from UT Southwestern, and his MBA from Duke University’s Fuqua School of Business. He completed his fellowship in hematology and oncology at Duke University. He and his wife have 2 young children keeping them busy.